- Product Details
Keywords
- supply high quality 99% Baricitinib intermediates 1187595-88-5
- Baricitinib intermediates 1187595-88-5 synthesis lab in China
- New products Baricitinib intermediates 1187595-88-5 99%
Quick Details
- ProName: Baricitinib intermediates 4-(1-(1-etho...
- CasNo: 1187595-88-5
- Molecular Formula: C19H29N5O2Si
- Appearance: white or light yellow crystalline powd...
- Application: used for synthesis Baricitinib
- DeliveryTime: Within 30 days after receipt of your o...
- PackAge: packaged in foil bags or tins
- Port: QINGDAO
- ProductionCapacity: 10 Kilogram/Month
- Purity:
- Storage: Store in a cool,dry place and keep awa...
- Transportation: by Air/Courier
- LimitNum: 10 Gram
- Moisture Content: 0.01%
- Impurity: 0.01%
- Melting Point:: 165
Superiority
Details




Baricitinib intermediates 1187595-88-5
Product Detail
4-(1-(1-ethoxyethyl)-1H-pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine
CAS:1187595-88-5
MF:C19H29N5O2Si
Appearance:solid
purity:98.5%
Application:Use as the pharma intermediates
Package |
as customers' requirements |
Storage |
Keep in cool, dry and ventilated place |
Transportation |
by Sea, air and express(EMS,DHL,TNT,FEDEX,UPS) |
Supply Ability |
500 Kilogram/Month |
Min Order |
10g |
Payment Term |
T/T,,MoneyGram,Other |
Delivery Time |
within 3 working days |










